• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于计算机断层扫描特征和临床病理因素构建预测结肠癌总生存期的列线图。

Constructing a nomogram to predict overall survival of colon cancer based on computed tomography characteristics and clinicopathological factors.

作者信息

Hu Zhe-Xing, Li Yin, Yang Xuan, Li Yu-Xia, He Yao-Yao, Niu Xiao-Hui, Nie Ting-Ting, Guo Xiao-Fang, Yuan Zi-Long

机构信息

Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, Hubei Province, China.

Department of Radiology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei Province, China.

出版信息

World J Gastrointest Oncol. 2024 Oct 15;16(10):4104-4114. doi: 10.4251/wjgo.v16.i10.4104.

DOI:10.4251/wjgo.v16.i10.4104
PMID:39473950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11514666/
Abstract

BACKGROUND

The colon cancer prognosis is influenced by multiple factors, including clinical, pathological, and non-biological factors. However, only a few studies have focused on computed tomography (CT) imaging features. Therefore, this study aims to predict the prognosis of patients with colon cancer by combining CT imaging features with clinical and pathological characteristics, and establishes a nomogram to provide critical guidance for the individualized treatment.

AIM

To establish and validate a nomogram to predict the overall survival (OS) of patients with colon cancer.

METHODS

A retrospective analysis was conducted on the survival data of 249 patients with colon cancer confirmed by surgical pathology between January 2017 and December 2021. The patients were randomly divided into training and testing groups at a 1:1 ratio. Univariate and multivariate logistic regression analyses were performed to identify the independent risk factors associated with OS, and a nomogram model was constructed for the training group. Survival curves were calculated using the Kaplan-Meier method. The concordance index (C-index) and calibration curve were used to evaluate the nomogram model in the training and testing groups.

RESULTS

Multivariate logistic regression analysis revealed that lymph node metastasis on CT, perineural invasion, and tumor classification were independent prognostic factors. A nomogram incorporating these variables was constructed, and the C-index of the training and testing groups was 0.804 and 0.692, respectively. The calibration curves demonstrated good consistency between the actual values and predicted probabilities of OS.

CONCLUSION

A nomogram combining CT imaging characteristics and clinicopathological factors exhibited good discrimination and reliability. It can aid clinicians in risk stratification and postoperative monitoring and provide important guidance for the individualized treatment of patients with colon cancer.

摘要

背景

结肠癌的预后受多种因素影响,包括临床、病理和非生物学因素。然而,仅有少数研究关注计算机断层扫描(CT)成像特征。因此,本研究旨在通过结合CT成像特征与临床和病理特征来预测结肠癌患者的预后,并建立列线图为个体化治疗提供关键指导。

目的

建立并验证用于预测结肠癌患者总生存期(OS)的列线图。

方法

对2017年1月至2021年12月间经手术病理确诊的249例结肠癌患者的生存数据进行回顾性分析。患者按1:1比例随机分为训练组和测试组。进行单因素和多因素逻辑回归分析以确定与OS相关的独立危险因素,并为训练组构建列线图模型。采用Kaplan-Meier法计算生存曲线。使用一致性指数(C指数)和校准曲线评估训练组和测试组中的列线图模型。

结果

多因素逻辑回归分析显示,CT上的淋巴结转移、神经周围侵犯和肿瘤分级是独立的预后因素。构建了包含这些变量 的列线图,训练组和测试组的C指数分别为0.804和0.692。校准曲线显示实际值与OS预测概率之间具有良好的一致性。

结论

结合CT成像特征和临床病理因素的列线图具有良好的区分度和可靠性。它可帮助临床医生进行风险分层和术后监测,并为结肠癌患者的个体化治疗提供重要指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11514666/5ef2d3b85956/WJGO-16-4104-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11514666/c6cc42320016/WJGO-16-4104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11514666/93d0ca5cd59e/WJGO-16-4104-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11514666/6f5f9f88eee7/WJGO-16-4104-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11514666/5ef2d3b85956/WJGO-16-4104-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11514666/c6cc42320016/WJGO-16-4104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11514666/93d0ca5cd59e/WJGO-16-4104-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11514666/6f5f9f88eee7/WJGO-16-4104-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11514666/5ef2d3b85956/WJGO-16-4104-g004.jpg

相似文献

1
Constructing a nomogram to predict overall survival of colon cancer based on computed tomography characteristics and clinicopathological factors.基于计算机断层扫描特征和临床病理因素构建预测结肠癌总生存期的列线图。
World J Gastrointest Oncol. 2024 Oct 15;16(10):4104-4114. doi: 10.4251/wjgo.v16.i10.4104.
2
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.不同肿瘤部位早发性结肠癌预后列线图的建立与验证:基于人群的研究。
BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1.
3
[Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].[伴有神经侵犯的进展期胃癌预测列线图模型的建立与验证]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
4
A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.基于检查淋巴结数量相关特征的列线图模型预测胃癌的预后并指导临床治疗。
Front Immunol. 2022 Nov 2;13:947802. doi: 10.3389/fimmu.2022.947802. eCollection 2022.
5
CT-based nomogram for predicting survival after R0 resection in patients with gallbladder cancer: a retrospective multicenter analysis.基于 CT 的胆囊癌 R0 切除术后生存预测列线图:一项回顾性多中心分析。
Eur Radiol. 2021 May;31(5):3336-3346. doi: 10.1007/s00330-020-07402-7. Epub 2020 Nov 13.
6
Development and validation of a prognostic nomogram for colorectal cancer after surgery.一种用于结直肠癌术后的预后列线图的开发与验证
World J Clin Cases. 2021 Jul 26;9(21):5860-5872. doi: 10.12998/wjcc.v9.i21.5860.
7
Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.预测 I-III 期老年结肠癌患者癌症特异性生存的列线图。
Scand J Gastroenterol. 2020 Feb;55(2):202-208. doi: 10.1080/00365521.2020.1720280. Epub 2020 Feb 1.
8
A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.一项包含美国癌症联合委员会(AJCC)分期的新型列线图能更好地预测接受手术的非小细胞肺癌患者的生存情况:一项基于大样本人群的研究。
J Oncol. 2020 May 20;2020:7863984. doi: 10.1155/2020/7863984. eCollection 2020.
9
Prognostic factors of patients with human epidermal growth factor receptor 2-positive breast cancer following neoadjuvant therapy: Development and validation of a predictive nomogram.人表皮生长因子受体 2 阳性乳腺癌患者新辅助治疗后预后因素:预测列线图的建立与验证。
Pathol Res Pract. 2024 Sep;261:155504. doi: 10.1016/j.prp.2024.155504. Epub 2024 Jul 31.
10
Establishment and validation of an individualized nomogram for survival prediction of primary mediastinal germ cell tumors based on the SEER database.基于监测、流行病学和最终结果(SEER)数据库建立并验证用于预测原发性纵隔生殖细胞肿瘤生存的个体化列线图。
Ann Transl Med. 2022 Sep;10(18):988. doi: 10.21037/atm-22-4181.

引用本文的文献

1
Clinicopathological and radiological characteristics and prediction of survival in colon cancer.结肠癌的临床病理和放射学特征及生存预测
World J Gastrointest Oncol. 2025 Feb 15;17(2):101516. doi: 10.4251/wjgo.v17.i2.101516.

本文引用的文献

1
The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients.化疗、原发肿瘤部位和组织学亚型对 III 期结肠癌患者生存的影响。
BMC Gastroenterol. 2023 Apr 5;23(1):110. doi: 10.1186/s12876-023-02741-3.
2
Survival rate of colorectal cancer in China: A systematic review and meta-analysis.中国结直肠癌的生存率:一项系统评价与荟萃分析。
Front Oncol. 2023 Mar 3;13:1033154. doi: 10.3389/fonc.2023.1033154. eCollection 2023.
3
Clinical characteristics and prognosis of 196 Chinese patients with colon cancer.
196例中国结肠癌患者的临床特征与预后
Front Surg. 2023 Jan 6;9:1008149. doi: 10.3389/fsurg.2022.1008149. eCollection 2022.
4
Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients.淋巴管浸润和血管浸润是预测 III 期结肠癌患者辅助化疗持续时间的预后和预测性病理因素。
BMC Cancer. 2023 Jan 3;23(1):3. doi: 10.1186/s12885-022-10416-7.
5
Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon Cancer.当前对结直肠癌预后和辅助化疗指导中病理特征重要性的认识。
Curr Oncol. 2022 Feb 23;29(3):1370-1389. doi: 10.3390/curroncol29030116.
6
Tumor enhancement ratio on preoperative abdominal contrast-enhanced CT scan for predicting recurrence risk in stage II colon cancer.术前腹部增强 CT 扫描肿瘤增强率预测 II 期结肠癌复发风险。
Abdom Radiol (NY). 2022 Apr;47(4):1265-1275. doi: 10.1007/s00261-022-03412-9. Epub 2022 Feb 11.
7
Correlation and prognostic value of CT-detected extramural venous invasion and pathological lymph-vascular invasion in colon cancer.CT 检测的结直肠癌外膜静脉侵犯与病理淋巴管侵犯的相关性及其预后价值。
Abdom Radiol (NY). 2022 Apr;47(4):1232-1243. doi: 10.1007/s00261-022-03414-7. Epub 2022 Feb 8.
8
Development and Internal Validation of a Nomogram-Based Model to Predict Three-Year and Five-Year Overall Survival in Patients with Stage II/III Colon Cancer.基于列线图的模型用于预测II/III期结肠癌患者三年和五年总生存率的开发及内部验证
Cancer Manag Res. 2022 Jan 14;14:225-236. doi: 10.2147/CMAR.S335665. eCollection 2022.
9
Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data.结直肠癌生存的全球模式与趋势:基于人群登记数据的系统综述
Cancer Biol Med. 2021 Sep 6;19(2):175-86. doi: 10.20892/j.issn.2095-3941.2020.0634.
10
Clinical Implications of Nonbiological Factors With Colorectal Cancer Patients Younger Than 45 Years.45岁以下结直肠癌患者非生物学因素的临床意义
Front Oncol. 2021 Jul 7;11:677198. doi: 10.3389/fonc.2021.677198. eCollection 2021.